aliskiren 300 mg
- Product Details
- Company Profile
Aliskiren(CAS No.173334-58-2) is an orally active renin inhibitor. It blocks angiotensin original cleavage to angiotensin I, which is the first step in blocking the renin - angiotensin system and it is also the step of speed - limite .
Compared with placebo, three doses of Aliskiren significantly reduced sitting DBP and SBP (P <.001). Antihypertensive effect of Aliskren 150 mg approaches to the effect of Irbesartan 150 mg (the average sitting position reduce DBP 9.5 + 8.0 and 9.0 + 7.9 mmHg lower SBP; respectively 10.8 + -- -- 12.4 and 12.5 + 14.2 mmHg); the average sitting position DBP of Aliskiren 300 mg and 600 mg is significantly greater than that of irbesartan 150mg (P <.05). Safety and tolerability of Aliskren and Irebesartan are similar to placebo.
Usually, the recommended starting dose for treating high blood pressure is 150 mg once daily. Your healthcare provider may increase your Tekturna dosage to 300 mg once daily if necessary.
Now, these two kinds of specifications ( aliskiren 150 mg and aliskiren 300 mg ) are in the market. You can look for what you want according to your need. You can search for the suppliers or the manufacturers of aliskiren on the Internet and then compare them. For example, you get the information of Hangzhou Holypharm biotech Co.,Ltd., a professional supplier of active pharmaceutical ingredients and intermediates, then you should know about the condition in-depth, including strength, the brand, the quality of the products, credit, service quality and so on. At last, the best is to get the products that you want at the best aliskiren price.
Verified Supplier
HANGZHOU HOLYPHARM BIOTECH CO.,LTD
- Country: China (Mainland)
- Year Established: 2009
- Business License:
- Business type: Other
- Integral:
Contact Details|Similar Products
Escrow ServiceMore
Secure Your Orders With escrow More Transparency,Less Uncertainty